590
N. SHIMIZU and Y. KUWAHARA
(R)-10-Bromo-1(6),8-p-methadien-2-one (3). According to the
procedure previously reported,5) (R)-(ꢀ)-carvone (7.5 g, 50 mmol)
was converted to bromide 3 in a 44% yield.
dihydropyran (336 mg, 4.0 mmol) in CH2Cl2 (10 ml) was stirred at rt
for 3 h. The mixture was diluted with EtOAc and successively washed
with water and brine. After drying over anhydrous Na2SO4, removal of
the solvent gave a residual oil, a crude THP ether, which was dissolved
in CH2Cl2 (20 ml) containing pyridine (320 ml, 4.0 mmol). Then, 30%
H2O2 (2.0 ml, 20 mmol) was added at 0 ꢃC, and the resulting solution
was stirred at rt for 1.5 h. To the solution was added water, and the
solution was extracted with EtOAc. The organic layer was washed with
brine and, after drying over anhydrous Na2SO4, the solvent was
removed in vacuo, leaving an oil which was dissolved in CCl4 (20 ml).
The mixture was refluxed for 30 min, and the solvent was removed
in vacuo. The resulting oil was dissolved in MeOH (5 ml) containing a
catalytic amount of p-TsOH. After stirring at rt for 1 h, the mixture was
diluted with EtOAc and successively washed with water and brine. The
organic layer was dried over anhydrous Na2SO4 and, after removing
the solvent in vacuo, an oil was left that, upon purification in a silica
gel column [7:1 hexane/EtOAc] afforded 6 as a colorless oil (246 mg,
56%). According to the same procedure, C(1) epimer 8 was prepared in
a 54% yield.
(R)-(ꢀ)-Cryptomerione. Magnesium turnings (8.0 g, 328 mmol)
were covered with THF (40 ml), and 1,2-dibromoethane (400 ml,
4.64 mmol) was added in one portion. After stirring the mixture for
1 min at rt, a solution of prenyl bromide (9.30 ml, 80.0 mmol) in THF
(120 ml) was added dropwise for 2 h at ꢀ15 ꢃC. The mixture was
stirred additionally for 2 h at 0 ꢃC, and the resulting solution (0.4–
0.45 M) was ready to use. To the cuprous bromide (5.16 g, 36.0 mmol)
were successively added a freshly prepared Grignard solution (160 ml)
and bromide 3 (2.75 g, 12.0 mmol) in THF (20 ml) at ꢀ15 ꢃC. After
being stirred for 30 min, the reaction mixture was quenched with
saturated NH4Cl and extracted with EtOAc. The organic layer was
washed with brine and dried over anhydrous Na2SO4. Evaporation of
the solvent in vacuo gave an oil which was chromatographed in a silica
gel column [17:1 hexane/EtOAc] to afford (R)-(ꢀ)-cryptomerione as a
25
colorless oil (1.52 g, 58%). ½ꢁꢁD ꢀ17:0 (c 1.0 CHCl3). GC-MS m=z
25
6: ½ꢁꢁD ꢀ120 (c 0.1 CHCl3). GC-MS m=z (%): 220 (Mþ, 6), 202
(%): 218 (Mþ, 11), 203 (4), 175 (24), 148 (54), 135 (41), 121 (23), 109
(63), 69 (100), 41 (54). 1H-NMR (400 MHz, CDCl3) ꢂ: 1.61 (s, 3H,
CH3), 1.65–1.74 (m, 1H, CHAHBCH2), 1.69 (d, J ¼ 1:2 Hz, 3H, CH3),
1.79 (dt, J ¼ 2:4 and 1.2 Hz, 3H, CH3), 2.04–2.13 (m, 3H,
CHAHBCH2), 2.28 (m, 1H, CHCHDCO), 2.35 (dd, J ¼ 16:0 and
13.2 Hz, 1H, CHEHFCH=), 2.46 (m, 1H, CHCHDCO), 2.59 (ddd,
J ¼ 16:0, 4.4 and 1.2 Hz, 1H, CHEHFCH=), 2.68 (m, 1H, CHCH2CO),
4.82 (s, 1H, CHGHH=), 4.85 (s, 1H, CHGHH=), 5.09 (tt, J ¼ 6:8 and
1.2 Hz, 1H, CH=C(CH3)2), 6.75 (ddd, J ¼ 5:6, 2.4 and 1.2 Hz, 1H,
CH2CH=C). 13C-NMR (100 MHz, CDCl3) ꢂ: 199.9, 150.8, 144.7,
135.4, 132.0, 123.7, 109.2, 43.5, 41.2, 34.3, 31.7, 26.6, 25.7, 17.7, 15.7.
(17), 187 (23), 159 (71), 151 (46), 109 (66), 91 (61), 69 (100), 41 (76).
1H-NMR (400 MHz, CDCl3) ꢂ: 1.05 (d, J ¼ 7:6 Hz, 3H, CH3), 1.53–
1.71 (m, 2H, CHCH2CH), 1.61 (s, 3H, CH3), 1.68 (d, J ¼ 1:2 Hz, 3H,
CH3), 2.00–2.17 (m, 4H, C(CH2)2CH), 2.38 (m, 1H, CHCH3), 2.97
(m, 1H, H-5), 3.97 (br.s, 1H, CHOH), 4.81 (s, 2H, CH2=), 5.11
(tq, J ¼ 6:8 and 1.4 Hz, 1H, CH=C(CH3)2), 5.48 (dtd, J ¼ 10:0, 2.4
and 0.8 Hz, 1H, H-4), 5.59 (ddd, J ¼ 10:0, 2.4 and 0.4 Hz, 1H, H-3).
13C-NMR (100 MHz, CDCl3) ꢂ: 152.5, 131.7, 130.3, 129.3, 124.1,
109.6, 68.7, 38.5, 34.9, 34.8, 34.4, 26.7, 25.7, 17.7, 16.0.
25
8: ½ꢁꢁD ꢀ30:5 (c 0.2 CHCl3). GC-MS m=z (%): 220 (Mþ, 4), 202
(9), 187 (14), 159 (31), 151 (37), 109 (71), 91 (49), 69 (100), 41 (66).
1H-NMR (400 MHz, CDCl3) ꢂ: 1.11 (d, J ¼ 7:2 Hz, 3H, CH3), 1.46–
1.77 (m, 2H, CHCH2CH), 1.61 (s, 3H, CH3), 1.69 (d, J ¼ 0:8 Hz, 3H,
CH3), 1.93–2.18 (m, 5H, C(CH2)2CH, CHCH3), 2.94 (m, 1H, H-5),
3.45 (ddd, J ¼ 11:6, 8.4 and 3.2 Hz, 1H, CHOH), 4.78 (dd, J ¼ 2:8 and
1.2 Hz, 1H, CHAHB=), 4.83 (d, J ¼ 0:4 Hz, 1H, CHAHB=), 5.11
(tt, J ¼ 7:2 and 1.4 Hz, 1H, CH=C(CH3)2), 5.46 (m, 2H, CH=CH).
13C-NMR (100 MHz, CDCl3) ꢂ: 152.4, 131.7, 131.5, 129.3, 124.1,
109.0, 74.5, 43.5, 39.3, 38.3, 34.0, 26.7, 25.7, 18.4, 17.7.
(1S,2S,3R,5S)-3-(Phenylseleno)-7(14),10-bisaboladien-1-ol (4) and
its C(1) epimer (5). Sodium borohydride (760 mg, 20.0 mmol) was
added in portions to a mixture of diphenyl diselenide (3.14 g,
10.0 mmol) in ethanol (25 ml) while stirring at rt. The colorless
(or faint yellow) solution of sodium benzeneselenolate obtained was
cooled to 0 ꢃC, and then acetic acid (1.30 ml, 23.0 mmol) was added. A
solution of (R)-(ꢀ)-cryptomerione (1.50 g, 10.0 mmol) in ethanol
(5 ml) was next added and the resulting mixture was stirred at 0 ꢃC for
2 h. The mixture was poured into water and extracted with EtOAc, and
the organic layer was successively washed with water and brine. After
drying over anhydrous Na2SO4, evaporation of the solvent in vacuo
gave an oil which was submitted to subsequent reduction without
purification. LiAlH4 (380 mg, 10.0 mmol) was added to a solution of
the crude selenenyl ketone (3.76 g, 10.0 mmol) in Et2O (70 ml) at
ꢀ10 ꢃC, and the mixture was stirred for 30 min. Excess hydride was
decomposed by adding wet ether, and the mixture was filtered.
Evaporation of the solvent in vacuo gave an oil which was purified in a
silica gel column [10:1–5:1 hexane/EtOAc] to afford 4 (2.65 g, 70%)
and 5 (718 mg, 19%).
(1S,2R,5S)-3,7(14),10-Bisabolatrien-1-ol (6) from (8).
A 40%
solution of DEAD in toluene (540 ml, 1.2 mmol) was added at 0 ꢃC
to a solution of 8 (88 mg, 0.40 mmol) in benzene (5 ml) containing
triphenylphosphine (524 mg, 2.0 mmol) and p-NO2C6H4CO2H
(200 mg, 1.20 mmol). The mixture was stirred at rt for 1 h and diluted
with EtOAc. After successively washing the mixture with water,
saturated NaHCO3 and brine, the organic layer was dried over
anhydrous Na2SO4. The solvent was removed in vacuo, leaving an oil
which was submitted to subsequent hydrolysis without purification. A
mixture of the crude ester and 1 M NaOH (1 ml) in MeOH (5 ml) was
stirred at rt for 1.5 h. The mixture was treated with 2N HCl and
extracted with EtOAc. The organic layer was successively washed with
water, saturated NaHCO3 and brine, and after drying (anhydrous
Na2SO4), the solvent was removed in vacuo, leaving an oil that, upon
purification in a silica gel column [8:1 hexane/EtOAc], afforded 6
(83 mg, 94%).
25
4: ½ꢁꢁD ꢀ172 (c 0.1 CHCl3). 1H-NMR (400 MHz, CDCl3) ꢂ: 1.24
(d, J ¼ 7:2 Hz, 3H, CH3), 1.49 (td, J ¼ 13:6 and 2.8 Hz, 1H, H-6A),
1.61 (s, 3H, CH3), 1.63 (td, J ¼ 13:6 and 3.6 Hz, 1H, H-6B), 1.69
(d, J ¼ 0:8 Hz, 3H, CH3), 1.84–2.16 (m, 7H, CHCH3, H-4,
C(CH2)2CH), 2.82 (tt, J ¼ 12:0 and 2.8 Hz, 1H, CH2CHCH2), 3.54
(q, J ¼ 3:6 Hz, 1H, CHSePh), 3.95 (br.s, 1H, CHOH), 4.74 (s, 1H,
CHCHD=), 4.76 (d, J ¼ 1:2 Hz, 1H, CHCHD=), 5.10 (tt, J ¼ 5:2 and
1.2 Hz, 1H, CH=C(CH3)2), 7.25 (m, 3H, aromatic of PhSe), 7.55
(m, 2H, aromatic of PhSe). 13C-NMR (100 MHz, CDCl3) ꢂ: 153.2,
134.0, 132.1, 131.6, 129.0, 127.1, 124.2, 107.9, 71.6, 49.4, 39.7, 38.6,
38.5, 35.2, 32.2, 26.8, 25.7, 18.0, 17.8.
(1S,2S,3S,4R,5R)-3,4-Epoxy-7(14),10-bisaboladien-1-ol (7). A mix-
ture of 6 (236 mg, 1.07 mmol), TBHP (70% aqueous solution, 284 ml,
2.14 mmol) and a catalytic amount of VO(acac)2 in benzene (10 ml)
was stirred at rt for 3 h. The mixture was diluted with EtOAc and
successively washed with saturated NaHCO3, water and brine. The
organic layer was dried over anhydrous Na2SO4 and, after removing
the solvent in vacuo, left epoxide 7 as an oil (237 mg, 94%) which was
submitted to subsequent oxidation without purification.
25
5: ½ꢁꢁD ꢀ208 (c 0.2 CHCl3). 1H-NMR (400 MHz, CDCl3) ꢂ: 1.23
(d, J ¼ 6:8 Hz, 3H, CH3), 1.62 (s, 3H, CH3), 1.58–1.71 (m, 2H, H-6),
1.69 (d, J ¼ 1:2 Hz, 3H, CH3), 2.00–2.15 (m, 7H, CHCH3, H-4,
C(CH2)2CH), 2.60 (tt, J ¼ 12:2 and 3.0 Hz, 1H, CH2CHCH2), 3.55 (td,
J ¼ 10:4 and 4.0 Hz, 1H, CHOH), 3.65 (q, J ¼ 3:2 Hz, 1H, CHSePh),
4.76 (s, 2H, CH2=), 5.09 (tt, J ¼ 8:8 and 1.6 Hz, 1H, CH=C(CH3)2),
7.25 (m, 3H, aromatic of PhSe), 7.56 (m, 2H, aromatic of PhSe). 13C-
NMR (100 MHz, CDCl3) ꢂ: 152.6, 134.4, 131.7, 130.7, 129.0, 127.3,
124.1, 108.0, 72.9, 52.7, 44.3, 40.9, 38.5, 38.1, 35.0, 26.8, 25.7, 17.8, 17.5.
25
½ꢁꢁD ꢀ25:6 (c 0.5 CHCl3). GC-MS m=z (%): 236 (Mþ, 3), 218
(4), 203 (4), 175 (17), 147 (16), 135 (16), 121 (16), 109 (23), 93 (23),
69 (100), 41 (54). 1H-NMR (400 MHz, CDCl3) ꢂ: 1.22 (d, J ¼ 7:2 Hz,
3H, CH3), 1.61–1.73 (m, 2H, CHCH2CH), 1.62 (s, 3H, CH3), 1.69
(s, 3H, CH3), 2.00–2.22 (m, 4H, C(CH2)2CH), 2.67 (d, J ¼ 11:2 Hz,
1H, CHCH3), 2.85 (dd, J ¼ 12:0 and 6.4 Hz, 1H, H-5), 3.20 (dd, J ¼
4:8 and 0.4 Hz, 1H, H-3), 3.23 (dd, J ¼ 4:8 and 1.2 Hz, 1H, H-4), 3.73
(m, 1H, CHOH), 4.90 (s, 1H, CHAHB=), 4.93 (s, 1H, CHAHB=), 5.11
(1S,2R,5S)-3,7(14),10-Bisabolatrien-1-ol (6) and its C(1) epimer
(8). A mixture of 4 (756 mg, 2.0 mmol), PPTS (51 mg, 0.20 mmol) and